PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

357 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
201.
Aguilar-Pimentel, J.A. et al.: Experimental allergen-specific immunotherapy under the umbrella of JAK1/3 pathway inhibition substantial improved local parameters of allergic airway inflammation. Allergy 71, 507-507 (2016)
202.
Antunes, C.M.* et al.: Allergenic profile of Quercus rotundifolia pollen in Alentejo, Portugal. Allergy 71, 213-214 (2016)
203.
Bieber, T.* et al.: Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: Challenges and opportunities toward precision medicine. Allergy 71, 588-592 (2016)
204.
Bousquet, J.* et al.: Paving the way of systems biology and precision medicine in allergic diseases: The MeDALL success story Mechanisms of the Development of ALLergy; EUFP7-CP-IP; Project No: 261357; 2010-2015. Allergy 71, 1513-1525 (2016)
205.
Brockow, K. et al.: Drug allergy passport and other documentation for patients with drug hypersensitivity - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 71, 1533-1539 (2016)
206.
Dietz, K. et al.: Age-dependent regulation of remodeling factors during allergic airway inflammation. Allergy 71, 31-32 (2016)
207.
Fischer, J.* et al.: Alpha-gal is a possible target of IgE-mediated reactivity to antivenom. Allergy 72, 764-771 (2016)
208.
Fuertes, E. et al.: Residential greenness is differentially associated with childhood allergic rhinitis and aeroallergen sensitization in seven birth cohorts. Allergy 71, 1461-1471 (2016)
209.
Graessel, A. ; Krause, L. ; Suttner, K. ; Schmidt-Weber, C.B. & Blank, S.: Searching for drug targets - Are Solute Carrier (SLC) transport proteins a promising target on human naive and activated CD4+T cells. Allergy 71, 223-224 (2016)
210.
Jakwerth, C.A. et al.: Systemic increase of regulatory B cells coincides with shift in effector T cell compartments following grass pollen-specific Immunotherapy. Allergy 71, 113-113 (2016)
211.
Kappen, J.* et al.: Evaluation of novel and current biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma. Allergy 71, 455-455 (2016)
212.
Keller, T.* et al.: Sex-switch of allergic rhinitis prevalence during adolescence - pooled analyses of longitudinal European birth cohort data from MeDALL. Allergy 71, 27-27 (2016)
213.
Marenholz, I.* et al.: Genome-wide association study unravels genetic determinants of the atopic march. Allergy 71, 431-431 (2016)
214.
Markevych, I. et al.: Early life travelling does not increase risk of asthma, allergies and atopy until 15 years: results from GINIplus and LISAplus. Allergy 71, 273-273 (2016)
215.
Michel, J.* et al.: Added sensitivity of component-resolved diagnosis in hymenoptera venom-allergic patients with elevated serum tryptase and/or mastocytosis. Allergy 71, 651-660 (2016)
216.
Olivieri, M.* et al.: The risk of respiratory symptoms on allergen exposure increases with increasing specific IgE levels. Allergy 71, 859-868 (2016)
217.
Russkamp, D. et al.: Alum-free thermosensitive hydrogel as matrix for immunomodulatory substances and allergens during allergen-specific immunotherapy. Allergy 71, 47-47 (2016)
218.
Schiener, M. et al.: Application of recombinant antigen 5 allergens from 7 allergy-relevant hymenoptera species in diagnostics. Allergy 72, 98-108 (2016)
219.
Schiener, M. et al.: C1q-like protein and PVF1 from honeybee venom show IgE-reactivity but do not activate basophils. Allergy 71, 178-178 (2016)
220.
von Berg, A.* et al.: Allergic manifestation 15 years after early intervention with hydrolyzed formulas - the GINI study. Allergy 71, 210-219 (2016)